Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer

The PROTECT consortium, H. R. Mortensen, P. Populaire, L. Hoffmann, D. S. Moeller, A. Appelt, P. Nafteux, C. T. Muijs, C. Grau, M. A. Hawkins, E. G.C. Troost, G. Defraene, R. Canters, C. S. Clarke, D. C. Weber, E. W. Korevaar, K. Haustermans, M. Nordsmark, Val Gebski, M. P. AchiamSheraz R. Markar, Ganesh Radhakrishna, Maaike Berbee, Daniele Scartoni, Ester Orlandi, Jerome Doyen, Vincent Gregoire, Gilles Crehange, Johannes Langendijk, Paula Lorgelly, Hedwig M. Blommenstein, Camilla S. Byskov, Mai L. Ehmsen, Maria Fuglsang Jensen, Gloria Vilches Freixas, Rebecca Bütoft

    Research output: Contribution to journalEditorialAcademicpeer-review

    2 Citations (Scopus)
    136 Downloads (Pure)
    Original languageEnglish
    Article number109980
    Number of pages3
    JournalRadiotherapy and Oncology
    Volume190
    DOIs
    Publication statusPublished - Jan-2024

    Cite this